Design of potent human steroid 5α-reductase inhibitors: 3D-QSAR CoMFA, CoMSIA and docking studies

被引:11
|
作者
Kumar, Rajnish [1 ]
Malla, Priyanka [1 ]
Verma, Abhilasha [1 ]
Kumar, Manoj [1 ]
机构
[1] Panjab Univ, Univ Inst Pharmaceut Sci, Chandigarh 160014, India
关键词
5; alpha-Reductase; Docking; Dihydrotestosterone; CoMFA; CoMSIA; MOLECULAR-FIELD ANALYSIS; SIMILARITY INDEXES; DERIVATIVES; FINASTERIDE; BINDING; QSAR;
D O I
10.1007/s00044-012-0456-5
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
3D-QSAR CoMFA, CoMSIA and docking studies were performed on a set of 4-azasteroidal human steroid 5 alpha-reductase inhibitors. The models developed using maximal common substructure-based alignment was found to be reliable and significant with good predictive r (2) value. CoMSIA model developed using combination of steric, electrostatic, hydrophobic, hydrogen bond donor and hydrogen bond acceptor features has shown r (cv) (2) = 0.564 with six optimum components, r (ncv) (2) = 0.945, F value = 101.196, r (Pred) (2) = 0.693 and SEE = 0.209. The contour plots obtained has shown a favourable effect of bulkier groups at C-17 position. Docking studies indicates the importance of bulkier groups at C-17 position for favourable activity. The study further helps in design of potent inhibitors of the enzyme.
引用
收藏
页码:4568 / 4580
页数:13
相关论文
共 50 条
  • [31] 3D-QSAR studies of latrunculin-based actin polymerization inhibitors using CoMFA and CoMSIA approaches
    Khanfar, Mohammad A.
    Youssef, Diaa T. A.
    El Sayed, Khalid A.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (09) : 3662 - 3668
  • [32] 3D-QSAR Studies on DATAs and DAPYs for HIV-RT Inhibitors using CoMFA and CoMSIA Approaches
    Park, Hyung Yeon
    Ju, Sun Mi
    Lee, Do Young
    Zhang, Hui
    Kim, Chan Kyung
    QSAR & COMBINATORIAL SCIENCE, 2009, 28 (02): : 218 - 225
  • [33] 3D-QSAR studies of checkpoint kinase 1 inhibitors based on molecular docking and CoMFA
    Wang, Rong Wei
    Zhou, Lu
    Zuo, Zhili
    Ma, Xiang
    Yang, Min
    MOLECULAR SIMULATION, 2010, 36 (02) : 87 - 110
  • [34] 3D-QSAR CoMFA and CoMSIA on protein tyrosine phosphatase 1B inhibitors
    Murthy, VS
    Kulkarni, VM
    BIOORGANIC & MEDICINAL CHEMISTRY, 2002, 10 (07) : 2267 - 2282
  • [35] The 3D-QSAR study of antitumor arylsulfonylimidazolidinone derivatives by CoMFA and CoMSIA
    Choo, HYP
    Choi, S
    Jung, SH
    Koh, HY
    Pae, AN
    BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (21) : 4585 - 4589
  • [36] 3D-QSAR COMFA AND COMSIA ON PROTEIN TYROSINE PHOSPHATASE 1B INHIBITORS
    Shukla, Vipasha
    Gupta, Swati
    Saxena, Anil K.
    MEDICINAL CHEMISTRY RESEARCH, 2010, 19 : S147 - S147
  • [37] QSAR studies of histone deacetylase (HDAC) inhibitors by CoMFA, CoMSIA, and molecular docking
    Zhang, Lei
    Fang, Hao
    Zhu, Huawei
    Wang, Qiang
    Xu, Wenfang
    DRUG DISCOVERIES AND THERAPEUTICS, 2009, 3 (02): : 41 - 48
  • [38] QSAR studies on diclofenac analogues as potent cyclooxygenase inhibitors using CoMFA and CoMSIA
    Arvind, K.
    Solomon, K. Anand
    Rajan, S. S.
    MEDICINAL CHEMISTRY RESEARCH, 2014, 23 (04) : 1789 - 1796
  • [39] 3D-QSAR CoMFA and CoMSIA study on benzodipyrazoles as cyclin dependent kinase 2 inhibitors
    Dessalew, Nigus
    Singh, Sanjeev Kumar
    MEDICINAL CHEMISTRY, 2008, 4 (04) : 313 - 321
  • [40] QSAR studies on diclofenac analogues as potent cyclooxygenase inhibitors using CoMFA and CoMSIA
    K. Arvind
    K. Anand Solomon
    S. S. Rajan
    Medicinal Chemistry Research, 2014, 23 : 1789 - 1796